113 related articles for article (PubMed ID: 6929706)
1. Immunosuppression and serious infections in children with acute lymphoblastic leukaemia: a comparison of three chemotherapy regimes.
Rapson NT; Cornbleet MA; Chessells JM; Bennett AJ; Hardisty RM
Br J Haematol; 1980 May; 45(1):41-52. PubMed ID: 6929706
[TBL] [Abstract][Full Text] [Related]
2. Analysis of treatment in childhood leukaemia. II. Timing and the toxicity of combined 6-mercaptopurine and methotrexate maintenance therapy.
MacLennan IC; Kay HE; Festenstein M; Smith PG
Br J Haematol; 1976 Jun; 33(2):179-88. PubMed ID: 1063593
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (B.C.G.), intermittent methotrexate, and no therapy after a five-month intensive cytotoxic regimen ((Concord trial). Preliminary report to the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood.
Br Med J; 1971 Oct; 4(5781):189-94. PubMed ID: 4940157
[TBL] [Abstract][Full Text] [Related]
4. Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood.
Chessells JM; Durrant J; Hardy RM; Richards S
J Clin Oncol; 1986 Dec; 4(12):1758-64. PubMed ID: 3537216
[TBL] [Abstract][Full Text] [Related]
5. The use of intermediate dose methotrexate in increased risk childhood acute lymphoblastic leukemia. A comparison of three versus six courses.
Green DM; Brecher ML; Blumenson LE; Grossi M; Freeman AI
Cancer; 1982 Dec; 50(12):2722-7. PubMed ID: 6958351
[TBL] [Abstract][Full Text] [Related]
6. Comparison of prednisolone, vincristine, methotrexate and 6-mercaptopurine vs. 6-mercaptopurine and prednisone maintenance therapy in childhood acute leukemia: a Southwest Oncology Group Study.
Berry DH; Fernbach DJ; Herson J; Pullen J; Sullivan MP; Vietti TJ
Cancer; 1980 Sep; 46(5):1098-1103. PubMed ID: 7011531
[TBL] [Abstract][Full Text] [Related]
7. Immunocompetence and prognosis in children with acute lymphoblastic leukemia: combination of two different maintenance therapies.
Garay GE; Pavlovsky S; Sasiain MC; Pizzolato MA; Binsztein N; Eppinger-Helft M
Med Pediatr Oncol; 1976; 2(4):403-15. PubMed ID: 1069898
[TBL] [Abstract][Full Text] [Related]
8. Maintenance chemotherapy for childhood acute lymphoblastic leukaemia: better in the evening.
Rivard GE; Infante-Rivard C; Hoyoux C; Champagne J
Lancet; 1985 Dec; 2(8467):1264-6. PubMed ID: 2866334
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intermittent or continuous methotrexate plus 6-mercaptopurine in regimens for standard-risk acute lymphoblastic leukemia in childhood (JCCLSG-S811). The Japanese Children's Cancer and Leukemia Study Group.
Koizumi S; Fujimoto T; Takeda T; Yatabe M; Utsumi J; Mimaya J; Ninomiya T; Yanai M
Cancer; 1988 Apr; 61(7):1292-300. PubMed ID: 3278798
[TBL] [Abstract][Full Text] [Related]
10. Effect of leukaemia therapy on neutrophil chemotaxis.
Thompson EN; Sarab-Al-Nakeeb
J Clin Pathol; 1981 Apr; 34(4):371-6. PubMed ID: 6940867
[TBL] [Abstract][Full Text] [Related]
11. The effect of folate supplements on 6-mercaptopurine remission maintenance therapy in childhood leukaemia.
Lennard L; Lilleyman JS; Maddocks JL
Br J Cancer; 1986 Jan; 53(1):115-9. PubMed ID: 3456241
[TBL] [Abstract][Full Text] [Related]
12. Analysis of treatment in childhood leukaemia. I. Predisposition to methotrexate-induced neutropenia after craniospinal irradiation. Report to the Medical Research Council of the Working Party on Leukaemia in Childhood.
Br Med J; 1975 Sep; 3(5983):563-6. PubMed ID: 1100179
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute lymphoblastic leukemia in children. Long-term results of two trials.
Cáp J; Koza I; Misíková Z; Foltinová A; Strbáková E
Neoplasma; 1983; 30(1):81-92. PubMed ID: 6339961
[TBL] [Abstract][Full Text] [Related]
14. Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia.
Chessells JM; Leiper AD; Tiedemann K; Hardisty RM; Richards S
Arch Dis Child; 1987 Feb; 62(2):172-6. PubMed ID: 3469936
[TBL] [Abstract][Full Text] [Related]
15. Analysis of treatment of childhood leukaemia. V. Advantage of reduced chemotherapy during and immediately after cranial irradiation.
MacLennan IC; Peto J; Kay HE
Br J Cancer; 1977 Nov; 36(5):625-33. PubMed ID: 412509
[TBL] [Abstract][Full Text] [Related]
16. Immunological follow-up of acute lymphoblastic leukaemia.
Krepler P; Pawlowsky J; Kummer M; Brunner R; Eibl M; Pawlowsky G
Haematologia (Budap); 1976; 10(1):11-22. PubMed ID: 1070465
[TBL] [Abstract][Full Text] [Related]
17. Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L.
Dahl GV; Rivera GK; Look AT; Hustu HO; Kalwinsky DK; Abromowitch M; Mirro J; Ochs J; Murphy SB; Dodge RK
J Clin Oncol; 1987 Jul; 5(7):1015-21. PubMed ID: 3474355
[TBL] [Abstract][Full Text] [Related]
18. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Mahoney DH; Camitta BM; Leventhal BG; Shuster JJ; Civin CJ; Ganick DJ; Lauer SJ; Steuber CP; Kamen BA
Cancer; 1995 May; 75(10):2623-31. PubMed ID: 7736409
[TBL] [Abstract][Full Text] [Related]
19. Cyclic chemotherapy in acute lymphoblastic leukaemia of childhood: 5-year survivals.
Vowels MR; Willoughby ML
Arch Dis Child; 1973 Jun; 48(6):436-40. PubMed ID: 4514541
[TBL] [Abstract][Full Text] [Related]
20. Organ irradiation and combination chemotherapy in treatment of acute lymphocytic leukaemia in children.
Lanzkowsky P; Shende A; Aral I; Saluja G
Arch Dis Child; 1975 Sep; 50(9):685-90. PubMed ID: 1059384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
